PortfoliosLab logoPortfoliosLab logo
LLY vs. UNH
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

LLY vs. UNH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eli Lilly and Company (LLY) and UnitedHealth Group Incorporated (UNH). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

LLY vs. UNH - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
LLY
Eli Lilly and Company
-14.27%40.25%33.30%60.91%34.26%66.08%31.04%16.14%40.45%17.83%
UNH
UnitedHealth Group Incorporated
-17.39%-33.14%-2.41%0.80%6.94%45.20%21.25%20.00%14.52%39.83%

Fundamentals

Market Cap

LLY:

$825.96B

UNH:

$246.24B

EPS

LLY:

$22.96

UNH:

$15.62

PE Ratio

LLY:

40.06

UNH:

17.32

PS Ratio

LLY:

12.68

UNH:

0.55

PB Ratio

LLY:

31.13

UNH:

2.46

Total Revenue (TTM)

LLY:

$65.18B

UNH:

$447.57B

Gross Profit (TTM)

LLY:

$54.62B

UNH:

$82.92B

EBITDA (TTM)

LLY:

$27.94B

UNH:

$23.19B

Returns By Period

In the year-to-date period, LLY achieves a -14.27% return, which is significantly higher than UNH's -17.39% return. Over the past 10 years, LLY has outperformed UNH with an annualized return of 30.92%, while UNH has yielded a comparatively lower 9.39% annualized return.


LLY

1D
3.74%
1M
-12.57%
YTD
-14.27%
6M
20.93%
1Y
12.19%
3Y*
39.90%
5Y*
39.16%
10Y*
30.92%

UNH

1D
3.36%
1M
-7.02%
YTD
-17.39%
6M
-20.50%
1Y
-46.88%
3Y*
-15.31%
5Y*
-4.29%
10Y*
9.39%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LLY vs. UNH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LLY
LLY Risk / Return Rank: 5151
Overall Rank
LLY Sharpe Ratio Rank: 5353
Sharpe Ratio Rank
LLY Sortino Ratio Rank: 4848
Sortino Ratio Rank
LLY Omega Ratio Rank: 4949
Omega Ratio Rank
LLY Calmar Ratio Rank: 5353
Calmar Ratio Rank
LLY Martin Ratio Rank: 5454
Martin Ratio Rank

UNH
UNH Risk / Return Rank: 1212
Overall Rank
UNH Sharpe Ratio Rank: 66
Sharpe Ratio Rank
UNH Sortino Ratio Rank: 1010
Sortino Ratio Rank
UNH Omega Ratio Rank: 66
Omega Ratio Rank
UNH Calmar Ratio Rank: 1515
Calmar Ratio Rank
UNH Martin Ratio Rank: 2525
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LLY vs. UNH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Eli Lilly and Company (LLY) and UnitedHealth Group Incorporated (UNH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


LLYUNHDifference

Sharpe ratio

Return per unit of total volatility

0.29

-0.92

+1.21

Sortino ratio

Return per unit of downside risk

0.69

-1.15

+1.84

Omega ratio

Gain probability vs. loss probability

1.10

0.81

+0.28

Calmar ratio

Return relative to maximum drawdown

0.42

-0.77

+1.19

Martin ratio

Return relative to average drawdown

1.02

-1.02

+2.04

LLY vs. UNH - Sharpe Ratio Comparison

The current LLY Sharpe Ratio is 0.29, which is higher than the UNH Sharpe Ratio of -0.92. The chart below compares the historical Sharpe Ratios of LLY and UNH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


LLYUNHDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.29

-0.92

+1.21

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

1.23

-0.14

+1.36

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

1.04

0.32

+0.73

Sharpe Ratio (All Time)

Calculated using the full available price history

0.56

0.60

-0.04

Correlation

The correlation between LLY and UNH is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

LLY vs. UNH - Dividend Comparison

LLY's dividend yield for the trailing twelve months is around 0.68%, less than UNH's 3.27% yield.


TTM20252024202320222021202020192018201720162015
LLY
Eli Lilly and Company
0.68%0.56%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%
UNH
UnitedHealth Group Incorporated
3.27%2.64%1.62%1.38%1.21%1.12%1.38%1.41%1.38%1.30%1.48%1.59%

Drawdowns

LLY vs. UNH - Drawdown Comparison

The maximum LLY drawdown since its inception was -68.24%, smaller than the maximum UNH drawdown of -74.37%. Use the drawdown chart below to compare losses from any high point for LLY and UNH.


Loading graphics...

Drawdown Indicators


LLYUNHDifference

Max Drawdown

Largest peak-to-trough decline

-68.24%

-74.37%

+6.13%

Max Drawdown (1Y)

Largest decline over 1 year

-30.26%

-60.06%

+29.80%

Max Drawdown (5Y)

Largest decline over 5 years

-34.48%

-61.39%

+26.91%

Max Drawdown (10Y)

Largest decline over 10 years

-34.48%

-61.39%

+26.91%

Current Drawdown

Current decline from peak

-17.00%

-55.14%

+38.14%

Average Drawdown

Average peak-to-trough decline

-19.25%

-14.63%

-4.62%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.39%

45.40%

-33.01%

Volatility

LLY vs. UNH - Volatility Comparison

Eli Lilly and Company (LLY) has a higher volatility of 9.04% compared to UnitedHealth Group Incorporated (UNH) at 7.72%. This indicates that LLY's price experiences larger fluctuations and is considered to be riskier than UNH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


LLYUNHDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.04%

7.72%

+1.32%

Volatility (6M)

Calculated over the trailing 6-month period

26.21%

29.34%

-3.13%

Volatility (1Y)

Calculated over the trailing 1-year period

42.44%

51.10%

-8.66%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

32.14%

31.26%

+0.88%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

29.80%

29.84%

-0.04%

Financials

LLY vs. UNH - Financials Comparison

This section allows you to compare key financial metrics between Eli Lilly and Company and UnitedHealth Group Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00B120.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
19.29B
113.22B
(LLY) Total Revenue
(UNH) Total Revenue
Values in USD except per share items

LLY vs. UNH - Profitability Comparison

The chart below illustrates the profitability comparison between Eli Lilly and Company and UnitedHealth Group Incorporated over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
85.1%
16.3%
Portfolio components
LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Eli Lilly and Company reported a gross profit of 16.41B and revenue of 19.29B. Therefore, the gross margin over that period was 85.1%.

UNH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, UnitedHealth Group Incorporated reported a gross profit of 18.49B and revenue of 113.22B. Therefore, the gross margin over that period was 16.3%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Eli Lilly and Company reported an operating income of 8.78B and revenue of 19.29B, resulting in an operating margin of 45.5%.

UNH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, UnitedHealth Group Incorporated reported an operating income of 380.00M and revenue of 113.22B, resulting in an operating margin of 0.3%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Eli Lilly and Company reported a net income of 6.64B and revenue of 19.29B, resulting in a net margin of 34.4%.

UNH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, UnitedHealth Group Incorporated reported a net income of 2.18B and revenue of 113.22B, resulting in a net margin of 1.9%.